- Report
- January 2024
- 182 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 181 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2021
- 76 Pages
Canada
From €3340EUR$3,500USD£2,799GBP
- Report
- January 2025
- 80 Pages
India
From €3340EUR$3,500USD£2,799GBP
- Report
- December 2024
- 85 Pages
Spain
From €3340EUR$3,500USD£2,799GBP
- Report
- September 2023
- 210 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2023
- 589 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2023
- 117 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- November 2022
- 119 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2024
- 106 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 132 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 115 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 113 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 113 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions.
The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs.
Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more